China SXT Pharmaceuticals (SXTC) Debt Ratio (2018 - 2026)
China SXT Pharmaceuticals (SXTC) posted quarterly Debt Ratio of 0.03 for Q1 2026, up 493.13% year-over-year from 0.0 in Q1 2025, and up 877.01% quarter-over-quarter from 0.0 in Q3 2025.
China SXT Pharmaceuticals (SXTC) Debt Ratio (2018 - 2026) Analysis & Trends
China SXT Pharmaceuticals' Debt Ratio history runs 9 years deep, the most recent figure standing at 0.03 for Q1 2026.
- In Q1 2026, Debt Ratio rose 493.13% year-over-year to 0.03; the TTM figure through Mar 2026 stood at 0.03 (up 493.13% YoY), while the FY2026 annual figure was 0.03, up 493.13% from the prior year.
- Debt Ratio for Q1 2026 stood at 0.03, up from 0.0 in the prior quarter.
- The five-year high for Debt Ratio was 0.05 in Q3 2022, with the low at 0.0 in Q3 2025.
- The 5-year median for Debt Ratio is 0.03 (2024), against an average of 0.02.
- The sharpest annual moves came in 2022 and 2026: Debt Ratio slumped 95.19% in 2022, then soared 493.13% in 2026.
- China SXT Pharmaceuticals' Debt Ratio stood at 0.05 in 2022, then plunged by 85.83% to 0.01 in 2023, then surged by 242.31% to 0.03 in 2024, then slumped by 88.84% to 0.0 in 2025, then soared by 877.01% to 0.03 in 2026.
- Business Quant data shows SXTC's Debt Ratio at 0.03 in Q1 2026, 0.0 in Q3 2025, and 0.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | -0.13 |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn | 0.42 |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn | 0.60 |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | 0.32 |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 0.38 |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 0.29 |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | 0.12 |
| 10 | China SXT Pharmaceuticals | 32,029.92 | -28.14 Mn | - | 0.03 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.03 |
| Sep 30, 2025 | 0.00 |
| Mar 31, 2025 | 0.00 |
| Sep 30, 2024 | 0.03 |
| Mar 31, 2024 | 0.03 |
| Sep 30, 2023 | 0.01 |
| Mar 31, 2023 | 0.01 |
| Sep 30, 2022 | 0.05 |
| Mar 31, 2022 | 0.03 |
| Sep 30, 2021 | 0.09 |
| Mar 31, 2021 | 0.70 |
| Sep 30, 2020 | 0.00 |
| Mar 31, 2020 | 0.31 |
| Sep 30, 2019 | 0.08 |
| Mar 31, 2019 | 0.14 |
| Sep 30, 2018 | 0.03 |